Microcirculatory function in postmenopausal women: Role of aging, hormonal exposure and metabolic syndrome

Microvascular Research

Volumn 78, Issue 3, 2009, Pages 405-412

  Clapauch, Ruth ^a,b   Mecenas, Anete S ^a   Maranhão, Priscila A ^a   Bouskela, Eliete ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL DA LAGOA   (Brazil)

Author keywords

Age; Endothelium; Hormone therapy; Menopause; Metabolic syndrome; Microcirculation; Oral contraceptives; Videocapillaroscopy

Indexed keywords

HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; AGED; AGING; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DRUG EXPOSURE; ERYTHROCYTE; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HORMONAL THERAPY; HUMAN; HYPEREMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MICROANGIOPATHY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGING; BLOOD FLOW VELOCITY; CAPILLARIES; ERYTHROCYTES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; ISCHEMIA; MENOPAUSE; METABOLIC SYNDROME X; MICROCIRCULATION; MIDDLE AGED; NAILS; TIME FACTORS; VIDEOTAPE RECORDING;

EID: 71549121938     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2009.08.003     Document Type: Article

References (46)

1. Abularrage C.J., Sidawy A.N., Aidinian G., Singh N., Weiswasser J.M., and Arora S. Evaluation of the microcirculation in vascular disease. J. Vasc. Surg. 42 3 (2005) 574-581
2. Alberti K.G., Zimmet P., and Shaw J. Metabolic syndrome-a new worldwide definition. A Consensus Statement from the International Diabetes Federation. Diabetic. Medicine. 2006. 23 5 (2006) 469-480
3. Alexandersen P., Tankó L.B., Bagger Y.Z., Qin G., and Christiansen C. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women. Climacteric 9 2 (2006) 108-118
4. Algotsson A. Serum lipids and lipoproteins are correlated to skin vessel reactivity in healthy women. J. Intern. Med. 239 2 (1996) 147-152
5. Anand S.S., Islam S., Rosengren A., Franzosi M.G., Steyn K., Yusufali A.H., Keltai M., Diaz R., Rangarajan S., Yusuf S., and INTERHEART Investigators. Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur. Heart. J. 29 7 (2008) 932-940
6. Anderson G.L., Limacher M., Assaf A.R., Bassford T., Beresford S.A., Black H., Bonds D., Brunner R., Brzyski R., Caan B., Chlebowski R., Curb D., Gass M., Hays J., Heiss G., Hendrix S., Howard B.V., Hsia J., Hubbell A., Jackson R., Johnson K.C., Judd H., Kotchen J.M., Kuller L., LaCroix A.Z., Lane D., Langer R.D., Lasser N., Lewis C.E., Manson J., Margolis K., Ockene J., O'Sullivan M.J., Phillips L., Prentice R.L., Ritenbaugh C., Robbins J., Rossouw J.E., Sarto G., Stefanick M.L., Van Horn L., Wactawski-Wende J., Wallace R., Wassertheil-Smoller S., and Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 14 (2004) 1701-1712
7. Anderson B., Kelly A.M., Kerr D., Clooney M., and Jolley D. Impact of patient and environmental factors on capillary refill time in adults. Am. J. Emerg. Med. 26 1 (2008) 62-65
8. Arora S., Veves A., Caballaro A.E., Smakowski P., and LoGerfo F.W. Estrogen improves endothelial function. J. Vasc. Surg. 27 6 (1998) 1141-1146 discussion 1147
9. Clapauch R., Athayde A., Meirelles R.M., Weiss R.V., Pardini D.P., Leão L.M., and Marinheiro L.P. Hormonal therapy of menopause: 2004 position of the Department of Female Endocrinology and Andrology of the Brazilian Society of Endocrinology and Metabolism. Arq. Bras. Endocrinol. Metabol. 49 3 (2005) 449-454
10. Clapauch R., Mattos T.M., Uchoa H.B., Ferreira A.S., Bonisson V.G., Lopes E.L., Nascimento I.C., and Bouskela E. Use of vascular Doppler ultrasound to detect acute estradiol vascular effect in postmenopausal women. Clinics 62 6 (2007) 673-678
11. Dancour M.A., Vaz J.L., Bottino D.A., and Bouskela E. Nailfold videocapillaroscopy in patients with systemic lupus erythematosus. Rheumatol. Int. 26 7 (2006) 633-637
12. de Simone G., Devereux R.B., Chinali M., Best L.G., Lee E.T., Galloway J.M., Resnick H.E., and Strong Heart Study Investigators. Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. Diabetes Care 30 7 (2007) 1851-1856
13. Dubey R.K., Imthurn B., Barton M., and Jackson E.K. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 66 2 (2005) 295-306
14. Félétou M., and Vanhoutte P.M. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am. J. Physiol. Heart. Circ. Physiol. 291 3 (2006) H985-1002
15. Gerhard M., Roddy M.A., Creager S.J., and Creager M.A. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. Hypertension 27 4 (1996) 849-853
16. Grodstein F., Stampfer M.J., Colditz G.A., Willett W.C., Manson J.E., Joffe M., Rosner B., Fuchs C., Hankinson S.E., Hunter D.J., Hennekens C.H., and Speizer F.E. Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 336 25 (1997) 1769-1775
17. Grodstein F., Manson J.E., and Stampfer M.J. Postmenopausal hormone use and secondary prevention of coronary events in the nurses' health study. a prospective, observational study. Ann. Intern. Med. 135 1 (2001) 1-8
18. Haenggi W., Linder H.R., Birkhaeuser M.H., and Schneider H. Microscopic findings of the nail-fold capillaries - dependence on menopausal status and hormone replacement therapy. Maturitas 22 1 (1995) 37-46
19. Heron M.P., and Smith B.L. Deaths: leading causes for 2003. Natl. Vital. Stat. Rep. 55 10 (2007) 1-92
20. Kalantaridou S.N., Naka K.K., Papanikolaou E., Kazakos N., Kravariti M., Calis K.A., Paraskevaidis E.A., Sideris D.A., Tsatsoulis A., Chrousos G.P., and Michalis L.K. Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. J. Clin. Endocrinol. Metab. 89 8 (2004) 3907-3913
21. Kelly R.I., Pearse R., Bull R.H., Leveque J.L., de Rigal J., and Mortimer P.S. The effects of aging on the cutaneous microvasculature. J. Am. Acad. Dermatol. 33 5 Pt. 1 (1995) 749-756
22. Klyscz T., Jünger M., Jung F., and Zeintl H. Cap image-ein neuartiges computerunterstütztes videoanalysesystem für die dynamische kapillarmikroskopie. Biomed. Tech. 42 (1997) 168-175
23. Koledova V.V., and Khalil R.A. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Expert. Rev. Cardiovasc. Ther. 5 (2007) 777-789
24. Kraemer-Aguiar L.G., Laflor C.M., and Bouskela E. Skin microcirculatory dysfunction is already present in normoglycemic subjects with metabolic syndrome. Metabolism 57 12 (2008) 1740-1746
25. Li L., Mac-Mary S., Sainthillier J.M., Nouveau S., de Lacharriere O., and Humbert P. Age-related changes of the cutaneous microcirculation in vivo. Gerontology. Gerontology 52 3 (2006) 142-153
26. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
27. Mendelsohn M.E., and Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340 23 (1999) 1801-1811
28. O'Donnell E., Harvey P.J., Goodman J.M., and De Souza M.J. Long-term estrogen deficiency lowers regional blood flow, resting systolic blood pressure, and heart rate in exercising premenopausal women. Am. J. Physiol. Endocrinol. Metab. 292 5 (2007) E1401-E1409
29. O'Rourke M.F. Arterial aging: pathophysiological principles. Vasc. Med. 12 4 (2007) 329-341
30. Orshal J.M., and Khalil R.A. Gender, sex hormones, and vascular tone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286 (2004) R233-R249
31. Qiao X., McConnell K.R., and Khalil R.A. Sex steroids and vascular responses in hypertension and aging. Gend. Med. 5 Suppl A (2008) S46-64
32. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., Jackson R.D., Beresford S.A., Howard B.V., Johnson K.C., Kotchen J.M., Ockene J., and Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 288 3 (2002) 321-333
33. Rossouw J.E., Prentice R.L., Manson J.E., Wu L., Barad D., Barnabei V.M., Ko M., LaCroix A.Z., Margolis K.L., and Stefanick M.L. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 297 13 (2007) 1465-1477 Erratum in: JAMA 299(12):1426
34. Sakashita T., Nobuzane T., Miyoshi H., Fujiwara H., and Kudo Y. Effects of menopause and hormone therapy on erythrocyte deformability. Menopause 16 3 (2009) 555-558
35. Sherwood A., Bower J.K., McFetridge-Durdle J., Blumenthal J.A., Newby L.K., and Hinderliter A.L. Age moderates the short-term effects of transdermal 17beta-estradiol on endothelium-dependent vascular function in postmenopausal women. Arterioscler. Thromb. Vasc. Biol. 27 8 (2007) 1782-1787
36. Simoncini T., Mannella P., Fornari L., Caruso A., Varone G., and Genazzani A.R. Genomic and non-genomic effects of estrogens on endothelial cells. Steroids 69 8-9 (2004) 537-542
37. Stevenson J.C. HRT and the primary prevention of cardiovascular disease. Maturitas 57 1 (2007) 31-34
38. Sumino H., Ichikawa S., Itoh H., Utsugi T., Ohyama Y., Umeda M., Nakamura T., Kanda T., Mizunuma H., Tomono S., Murakami M., and Kurabayashi M. Hormone replacement therapy decreases insulin resistance and lipid metabolism in Japanese postmenopausal women with impaired and normal glucose tolerance. Horm. Res. 60 (2003) 134-142
39. Taddei S., Virdis A., Mattei P., Ghiadoni L., Gennari A., Fasolo C.B., Sudano I., and Salvetti A. Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91 7 (1995) 1981-1987
40. Tao J., Jin Y.F., Yang Z., Wang L.C., Gao X.R., Lui L., and Ma H. Reduced arterial elasticity is associated with endothelial dysfunction in persons of advancing age: comparative study of noninvasive pulse wave analysis and laser Doppler blood flow measurement. Am. J. Hypertens. 17 8 (2004) 654-659
41. Teede H.J. Sex hormones and the cardiovascular system: effects on arterial function in women. Clin. Exp. Pharmacol. Physiol. 34 7 (2007) 672-676
42. Versari D., Daghini E., Virdis A., Ghiadoni L., and Taddei S. The aging endothelium, cardiovascular risk and disease. Exp. Physiol. 94 3 (2009) 317-321
43. Virdis A., Pinto S., Versari D., Salvetti G., Bernini G., Fruzzetti F., Genazzani A.R., Taddei S., and Salvetti A. Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J. Hypertens. 21 12 (2003) 2275-2280
44. Vitale C., Mercuro G., Cerquetani E., Marazzi G., Patrizi R., Pelliccia F., Volterrani M., Fini M., Collins P., and Rosano G.M. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler. Thromb. Vasc. Biol. 28 2 (2008) 348-352
45. Wilson P.W.F., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
46. Wynne F.L., and Khalil R.A. Testosterone and coronary vascular tone: implications in coronary artery disease. J. Endocrinol. Invest. 26 (2003) 181-186